Hypovitaminosis D in primary hyperparathyroidism: To treat or not to treat? That is the question

Journal of Endocrinological Investigation

Volumn 37, Issue 5, 2014, Pages 413-414

  Minisola, Salvatore ^a   Romagnoli, Elisabetta ^a   Scillitani, Alfredo ^b   Rao, Sudhakar D ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; OXYGENASE; PARATHYROID HORMONE; VITAMIN D;

BONE DENSITY; CALCIUM BLOOD LEVEL; EDITORIAL; HORMONE SYNTHESIS; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; META ANALYSIS (TOPIC); OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PRIMARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; COMPLICATION; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; MALE;

CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; VITAMIN D DEFICIENCY;

EID: 84900563591     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0060-2     Document Type: Editorial

References (18)

1. Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S (2013) Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169:R59-R69
2. Carnevale V, Manfredi G, Romagnoli E, De Geronimo S, Paglia F, Pepe J, Scillitani A, D'Erasmo E, Minisola S (2004) Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol (Oxf). 60:81-86 (Pubitemid 38183502)
3. Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165:851-864
4. Shah VN, Shah CS, Bhadada SK, Rao DS (2014) Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Clin Endocrinol (Oxf). doi:10.1111/cen.12398. [Epub ahead of print]
5. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107:561-567
6. Rao DS (1999) Perspective on assessment of vitamin D nutrition. J Clin Densitom 2:457-464
7. Zierold C, Mings JA, DeLuca HF (2003) Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone. J Cell Biochem 88:234-237 (Pubitemid 36119892)
8. Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH (1987) Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci (Lond). 73:659-664 (Pubitemid 18013299)
9. Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 63:506-513 (Pubitemid 41626744)
10. Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, Talpos GB, Parfitt AM (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054-1058 (Pubitemid 32269349)
11. Stein EM, Dempster DW, Udesky J, Zhou H, Bilezikian JP, Shane E, Silverberg SJ (2011) Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone 48:557-561
12. Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P (2014) Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab jc20133978. [Epub ahead of print]
13. Rathi M, Gonzalez S, Ellis N, Wright D, Peacey S (2014) Management of hypovitaminosis D in patients with primary hyperparathyroidism. J Endocrinol Invest. doi:10.1007/s40618-014-0056-y
14. Isidro ML, Ruano B (2009) Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 36:305-310
15. Tucci JR (2009) Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur J Endocrinol 161:189-193
16. Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 90:2122-2126 (Pubitemid 40586249)
17. Minisola S, Romagnoli E, Scarnecchia L, Rosso R, Pacitti MT, Scarda A, Mazzuoli G (1994) Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: studies in basal conditions and after parathyroid surgery. Eur J Endocrinol 130:587-591 (Pubitemid 24203413)
18. Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli G (1988) Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Miner Electrolyte Metab 14:201-207